Mounjaro Adverse Events: A UK Guide (October 2026)

01 · The core answer

What do Mounjaro adverse events actually mean?

An adverse event is any unwanted medical occurrence while someone is taking a medicine. It does not prove the medicine caused it. Regulators sort these reports, and the ones judged to be linked become listed side effects in the product information.¹

For Mounjaro (tirzepatide), the most common side effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks.

Tirzepatide activates two natural gut-hormone receptors, GIP and GLP-1. Together they help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹

02 · Your decision

Is this relevant to me, and what should I do next?

If you are already taking Mounjaro, the practical steps are simple: read the leaflet that came with your pen, keep your monthly review, and tell your prescriber about anything new. If you are still deciding, the safety information is something to read before you start, alongside your own medical history, which the prescriber will review.

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹ Our free consultation is no obligation, and ongoing monthly reviews and side-effect support are part of our aftercare. If you are ready to look at treatment, see the Mounjaro pen prices and consultation page. For broader context, our weight loss clinic page explains the wider service.

Related reading: our guide to Mounjaro adverse side effects covers the day-to-day experience in more practical terms.

03 · Events versus side effects

Adverse events versus side effects

The two terms are used loosely online, but they mean different things. An adverse event is anything unwanted that occurs during treatment, including coincidences such as a cold or a minor injury. A side effect, or adverse reaction, is an effect the medicine is recognised to cause.

This matters when you read trial papers. A trial table of adverse events will list everything that happened in the treatment group and the comparison group. The useful signal is the difference between them, and that is how regulators decide what goes into the product information.¹

It also matters when you read social media. A symptom someone links to Mounjaro online is not necessarily a listed side effect; a symptom that is not on the UK patient leaflet list is not a listed side effect. If you notice a symptom that is not listed, tell your prescriber about any new or lasting symptom.

04 · Where the list lives

Where to find the official Mounjaro side effect list

The official list is in two documents. The Summary of Product Characteristics is written for clinicians and sets out the side effects, warnings and interactions.¹ The patient information leaflet is the plain-English version that comes in every pack.¹³ The BNF entry for tirzepatide gives a clinician-facing summary of indications, dosing and safety.¹¹

05 · GLP-1 trial safety data

What GLP-1 adverse events look like in trials

In STEP 1, gastrointestinal side effects were reported by 74.2% of people on semaglutide 2.4mg, compared with 47.9% on placebo. 7.0% stopped treatment because of side effects, compared with 3.1% on placebo.⁹

Do not set those semaglutide figures against tirzepatide figures from a different trial as if they were a head-to-head result. Only SURMOUNT-5 compared the two directly, over 72 weeks in adults taking tirzepatide or semaglutide 2.4mg.¹⁵

06 · SURMOUNT-OSA

SURMOUNT-OSA tirzepatide adverse events

SURMOUNT-OSA studied tirzepatide in adults with obstructive sleep apnoea and obesity, and its adverse event data are published in the NEJM paper.¹⁶

If sleep apnoea is your reason for looking, our Mounjaro OSA page covers the topic, and the AHI reduction, hsCRP reduction and weight loss percentage pages break down the efficacy results. Any treatment decision for sleep apnoea belongs with your clinician.

07 · Interactions and precautions

What to avoid or tell your prescriber about

Two interactions are worth knowing before you start. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar. If you take insulin or a sulfonylurea, watch for low blood sugar; your prescriber may need to adjust those medicines.¹

Tell the prescriber about every medicine you take, including over-the-counter products and supplements. Marketing that promises dramatic weight-loss claims from supplements is not evidence of safety or effect, and low-cost supplements come with no clinical oversight.

Treat any seller offering to supply Mounjaro without a consultation or prescription as a red flag. Counterfeit medicine alerts and the Yellow Card scheme are covered by the MHRA.⁷ You can check our registration, GPhC 9012878, on the GPhC register.¹²

08 · Reporting and stopping

Reporting a side effect and stopping treatment

You can report any suspected side effect yourself through the MHRA Yellow Card scheme, and you do not need to be certain the medicine caused it.¹⁹ Reports help regulators spot patterns. Tell your prescriber too, so your plan can be reviewed.

Stopping Mounjaro abruptly is a decision to take with your prescriber, mainly so you know what to expect next. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Trial averages do not predict your own result, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² The SURMOUNT-4 paper studied continued treatment for maintenance of weight reduction if you want the primary data.¹⁴

09 · Long-term effects

Long-term effects and irreversible harm

The long-term picture is documented in the SmPC and kept under review by regulators, so check the current version rather than relying on a summary.¹ If a symptom persists after a dose change or after stopping, speak to a clinician.

Treatment is intended to be reviewed over time. NICE has published a practical prescribing guide that covers how treatment is managed.⁴ Mounjaro is available on the NHS, but access is being phased in over several years, with the primary-care rollout beginning in June 2025 for the highest-need groups first.⁴

You may also find the Romanian-language reactii adverse page useful, and our Mounjaro ICD-10 page explains the coding side of medical records.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹